-0.63 | -0.62%
| Price and Volume | |
|---|---|
| Recent Price | 101.39 |
| 52 Week High | 124.62 |
| 52 Week Low | 84.02 |
| Avg. Daily Vol. (Mil) | 0.10 |
| Beta (3 year) | 1.24 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,344.02 |
| Shares Out (Mil) | 28.24 |
| Float (Mil) | 19.39 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.70 |
| Current Ratio | 4.10 |
| LT Debt/ Equity | 0.40 |
| Total Debt / Equity | 0.40 |
| Valuation Ratios | |
| Price Earnings | 16.40 |
| Price/Sales | 1.38 |
| Price/Book | 1.56 |
| Price/Cash Flow | 9.50 |
| Per Share Data | |
| Earnings | 6.19 |
| Sales | 73.46 |
| Book Value | 65.13 |
| Cash Flow | 10.63 |
| Business Summary | |
|---|---|
| Bio-Rad Laboratories, Inc. is a manufacturer and worldwide distributor of its own life science research and clinical diagnostics products. | |
| General Information | |
| 1000 Alfred Nobel Drive
Hercules, CA 94547 |
|
| www.bio-rad.com | |
| Industry : Electronics | |
| Sector: Technology | |
| Employees: 7030 | |
| CEO: Norman Schwartz | |
| Short Interest | |
| Current Month (Mil) | 0.20 |
| Previous Month (Mil) | 0.26 |
| Short Interest Ratio (Days) | 2.10 |
| Management Effectiveness | |
| Return on Equity | 9.60 |
| Return on Assets | 5.50 |
| Return on Investments | 6.90 |
| Profitability | |
| Gross Margin | 62.80 |
| EBIT Margin | 13.70 |
| Profit Margin | 8.50 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet